What Are the Available Contraceptive Methods for Women?

Women have several evidence-based contraceptive options, each with distinct mechanisms of action, efficacy profiles, and suitability depending on individual health, lifestyle, and reproductive goals. The primary categories include hormonal methods, barrier methods, long-acting reversible contraceptives (LARCs), permanent sterilization, and fertility awareness–based methods.

Hormonal contraceptives work by suppressing ovulation, thickening cervical mucus to impede sperm transport, and altering the endometrial lining to reduce implantation potential. These include combined oral contraceptives (containing estrogen and progestin), progestin-only pills (minipills), contraceptive patches, vaginal rings, and injectables such as depot medroxyprogesterone acetate (DMPA). Hormonal methods are highly effective with typical-use failure rates ranging from 3% to 9%, depending on adherence and formulation.

Barrier methods—such as male and female condoms, diaphragms, and cervical caps—physically prevent sperm from reaching the cervix. While they offer no hormonal effects and provide some protection against sexually transmitted infections (STIs), their typical-use effectiveness is lower (12–21% failure rate), largely due to inconsistent or incorrect use.

Long-acting reversible contraceptives represent the most effective reversible options. Intrauterine devices (IUDs) include copper IUDs (nonhormonal, spermicidal via inflammatory response) and hormonal IUDs (releasing levonorgestrel to suppress endometrial proliferation and thicken cervical mucus). Subdermal implants—single-rod devices placed in the upper arm—deliver steady-state etonogestrel for up to three years. With perfect-use failure rates below 0.2%, LARCs eliminate user-dependent variables and are recommended as first-line options by major guidelines, including those from the American College of Obstetricians and Gynecologists (ACOG) and the World Health Organization (WHO).

Permanent contraception includes tubal ligation for women and vasectomy for male partners. Tubal ligation involves surgical occlusion or removal of the fallopian tubes and carries a failure rate of less than 0.5%. Though considered irreversible, advances in microsurgical reversal and assisted reproductive technologies have expanded post-sterilization options—but these should not be assumed when counseling patients.

Fertility awareness–based methods (FABMs) rely on tracking menstrual cycle biomarkers—including basal body temperature, cervical mucus characteristics, and urinary luteinizing hormone (LH) surges—to identify the fertile window. When used consistently and correctly, some FABMs demonstrate failure rates as low as 1–5%; however, typical-use failure exceeds 20% due to variability in cycle regularity and observational rigor. These methods require dedicated instruction and are best suited for motivated individuals seeking nonhormonal, non-invasive approaches.

Choice of contraceptive method should be individualized through shared decision-making, incorporating medical contraindications (e.g., history of thromboembolism, uncontrolled hypertension, or breast cancer), patient preferences, access, and cultural considerations. Regular follow-up ensures continued satisfaction, addresses side effects, and supports timely method switching when needed.